Professional Documents
Culture Documents
The American Diabetes Association (ADA) criteria for the diagnosis of diabetes are any of the following[1] : An HbA1c level of 6.5% or higher; the test should be performed in a laboratory using a method that is certified by the National Glycohemoglobin Standardization Program (NGSP) and standardized or traceable to the Diabetes Control and Complications Trial (DCCT) reference assay, or A fasting plasma glucose (FPG) level of 126 mg/dL (7.0 mmol/L) or higher; fasting is defined as no caloric intake for at least 8 hours, or A 2-hour plasma glucose level of 200 mg/dL (11.1 mmol/L) or higher during a 75-g oral glucose tolerance test (OGTT), or A random plasma glucose of 200 mg/dL (11.1 mmol/L) or higher in a patient with classic symptoms of hyperglycemia (ie, polyuria, polydipsia, polyphagia, weight loss) or hyperglycemic crisis The American Association of Clinical Endocrinologists, however, recommends that HbA1c be considered an additional optional diagnostic criterion, rather than a primary criterion for diagnosis of diabetes. [88] If unequivocal hyperglycemia is absent, then HbA1c, FPG, and OGTT results should be confirmed by repeat testing. The ADA recommends repeating the same test for confirmation, since there will be a greater likelihood of concurrence. However, the diagnosis of diabetes is also confirmed if the results of 2 different tests are above the diagnostic thresholds.[2] If a patient has had 2 different tests and the results are discordant, the test that has a result above the diagnostic threshold should be repeated. A second abnormal result on this test will confirm the diagnosis.[89] In asymptomatic patients whose random serum glucose level suggests diabetes (>140 mg/dL), an FPG or HbA1c level should be measured. An FPG level of 100-125 mg/dL is considered an impaired fasting glucose (IFG), and an FPG level of less than 100 mg/dL is considered a normal fasting glucose. However, an FPG of 91-99 mg/dL is a strong independent predictor of future type 2 diabetes.[90] An HbA1c below 6% is considered normal glucose tolerance (using an assay that has been standardized to the DCCT normal range of 4-6%). An HbA1C of 6-6.4% is neither normal glucose tolerance nor diabetes. In the emergency department, a fingerstick glucose test is appropriate for virtually all patients with diabetes. All other laboratory studies should be individualized to the clinical situation. [91]
Glucose Studies
Plasma glucose is determined using blood drawn into a gray-top (sodium fluoride) tube, which inhibits red blood cell glycolysis immediately. A serum glucose measurement (commonly obtained on chemistry panels, using a red- or speckled-top tube) may be significantly lower than a plasma glucose measurement. Capillary whole blood measurements are not recommended for the diagnosis of diabetes mellitus, but they are valuable for assessment of patients in acute care situations. The noted values for fasting glucose measurements are based on the level of glycemia at which retinopathy, a fairly pathognomonic diabetic complication, appears. (However, evidence suggests that retinopathy may occur even in prediabetes.) Fasting glucose measurements are not as predictive for indicating macrovascular risk as are postglucose load values. However, there are no formal recommendations for using glucose tolerance tests for this purpose.
These criteria are a better predictor of increased macrovascular risk than the ADA's current intermediate category of IFG or prediabetes. Presumably, patients with IFG are at increased risk for development of diabetes mellitus, but their risk for macrovascular disease does not appear to be the same as for patients with IGT (which is about the same as for patients with frank type 2 diabetes mellitus).
postprandial blood glucose and was therefore a better marker of diabetes in neonates. This finding is important to neonatologist and those caring for newborns.[98] A study by Wilson et al (in patients with type 1 diabetes) found persistent individual variations in the rate at which individuals glycate hemoglobin. These variations may contribute to inaccuracy in estimating mean glucose concentration from the HbA1c level.[99]
Member of a high-risk ethnic population (eg, African American, Latino, Native American, Asian American, Pacific Islander) Delivered a baby weighing over 9 lb or diagnosed with gestational diabetes mellitus Hypertension (140/90 mm Hg or on therapy for hypertension) HDL cholesterol level under 35 mg/dL (0.90 mmol/L) and/or a triglyceride level above 250 mg/dL (2.82 mmol/L) Polycystic ovary disease IGT or IFG on previous testing Other clinical conditions associated with insulin resistance (eg, severe obesity, acanthosis nigricans) History of cardiovascular disease In the absence of the above criteria, the ADA recommends testing for prediabetes and diabetes beginning at age 45 years. If results are normal, testing should be repeated at least every 3 years. More frequent testing may be considered, depending on initial results and risk status.